Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for February 2026

Showing all data including statistical outliers.Hide Outliers
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

DraftKings Inc. (DKNG)

SLOAN HARRY โ€” Director
Feb 17, 2026
Purchase
Shares
100,000
Price
$21.85
Total Value
$2.19M
Shares Held After
350,219
% of Holdings
28.6%
Feb 17, 2026
Sale
Shares
5,025
Price
$321.08
Total Value
$1.61M
Shares Held After
12,284
% of Holdings
29.0%

TFS Financial CORP (TFSL)

Stefanski Marc A โ€” Director
Feb 17, 2026
Sale
Shares
36,844
Price
$15.12
Total Value
$557.08K
Shares Held After
71,997
% of Holdings
33.9%

ADMA BIOLOGICS, INC. (ADMA)

Grossman Adam S โ€” Director
Feb 17, 2026
Sale
Shares
6,000
Price
$16.08
Total Value
$96.48K
Shares Held After
2,284,379
% of Holdings
0.3%

ADMA BIOLOGICS, INC. (ADMA)

Grossman Adam S โ€” Director
Feb 17, 2026
Sale
Shares
15,000
Price
$16.08
Total Value
$241.20K
Shares Held After
2,290,379
% of Holdings
0.7%

Cinedigm Corp. (CIDM)

OPEKA ERICK โ€” CSO and President
Feb 17, 2026
Purchase
Shares
30,000
Price
$2.00
Total Value
$60.00K
Shares Held After
224,146
% of Holdings
13.4%

Noble Corp plc (NE)

Denton Blake โ€” SVP, Marketing & Contracts
Feb 17, 2026
Sale
Shares
23,255
Price
$43.50
Total Value
$1.01M
Shares Held After
79,261
% of Holdings
22.7%

Noble Corp plc (NE)

IPSEN MIKKEL โ€” SVP, Human Resources
Feb 17, 2026
Sale
Shares
3,453
Price
$43.56
Total Value
$150.41K
Shares Held After
11,854
% of Holdings
22.6%

Cinedigm Corp. (CIDM)

MCGURK CHRISTOPHER J โ€” Director
Feb 17, 2026
Purchase
Shares
75,000
Price
$2.00
Total Value
$150.00K
Shares Held After
178,526
% of Holdings
42.0%

Cinedigm Corp. (CIDM)

LOFFREDO GARY S โ€” CLO, Secretary and Sr Advisor
Feb 17, 2026
Purchase
Shares
30,000
Price
$2.00
Total Value
$60.00K
Shares Held After
200,337
% of Holdings
15.0%

Cinedigm Corp. (CIDM)

Torres Mark โ€” Chief People Officer
Feb 17, 2026
Purchase
Shares
25,000
Price
$2.00
Total Value
$50.00K
Shares Held After
183,274
% of Holdings
13.6%

Cinedigm Corp. (CIDM)

Macias Yolanda โ€” Chief Motion Pictures Officer
Feb 17, 2026
Purchase
Shares
30,000
Price
$2.00
Total Value
$60.00K
Shares Held After
121,760
% of Holdings
24.6%
Feb 17, 2026
Purchase
Shares
35,000
Price
$2.00
Total Value
$70.00K
Shares Held After
154,168
% of Holdings
22.7%

Cinedigm Corp. (CIDM)

Huidor Mark Antonio โ€” Pres Tech/Chief Product Off
Feb 17, 2026
Purchase
Shares
37,500
Price
$2.00
Total Value
$75.00K
Shares Held After
190,061
% of Holdings
19.7%

Gemini Therapeutics, Inc. (GMTX)

Yu Jonathan Yen-Wen โ€” Chief Operating Officer
Feb 17, 2026
Sale
Shares
3,231
Price
$62.86
Total Value
$203.10K
Shares Held After
54,324
% of Holdings
5.6%
Feb 17, 2026
Sale
Shares
13,264
Price
$62.86
Total Value
$833.78K
Shares Held After
226,064
% of Holdings
5.5%
Feb 17, 2026
Purchase
Shares
290,000
Price
$15.59
Total Value
$4.52M
Shares Held After
16,310,563
% of Holdings
1.8%

Gemini Therapeutics, Inc. (GMTX)

Savage William Jacob โ€” Chief Medical Officer
Feb 17, 2026
Sale
Shares
3,256
Price
$62.86
Total Value
$204.67K
Shares Held After
92,589
% of Holdings
3.4%

Gemini Therapeutics, Inc. (GMTX)

Khara Rahul โ€” Chief Legal Officer
Feb 17, 2026
Sale
Shares
2,853
Price
$62.86
Total Value
$179.34K
Shares Held After
52,173
% of Holdings
5.2%

Gemini Therapeutics, Inc. (GMTX)

Stephenson Pamela โ€” Chief Commercial Officer
Feb 17, 2026
Sale
Shares
5,531
Price
$62.86
Total Value
$347.68K
Shares Held After
80,998
% of Holdings
6.4%

MediaAlpha, Inc. (MAX)

Cramer Keith โ€” Chief Revenue Officer
Feb 17, 2026
Sale
Shares
10,000
Price
$7.16
Total Value
$71.60K
Shares Held After
182,154
% of Holdings
5.2%

PULSE BIOSCIENCES, INC. (PLSE)

Danahy Kevin Patrick โ€” Chief Commercial Officer
Feb 17, 2026
Sale
Shares
20,000
Price
$23.63
Total Value
$472.60K
Shares Held After
43,298
% of Holdings
31.6%
Feb 17, 2026
Sale
Shares
127,632
Price
$49.12
Total Value
$6.27M
Shares Held After
449,078
% of Holdings
22.1%

Avidbank Holdings, Inc. (AVBH)

ROSINUS MIKE โ€” Director
Feb 17, 2026
Sale
Shares
5,076
Price
$30.17
Total Value
$153.15K
Shares Held After
183,122
% of Holdings
2.7%
Feb 17, 2026
Sale
Shares
47,648
Price
$5.06
Total Value
$241.10K
Shares Held After
409,815
% of Holdings
10.4%

Aura Biosciences, Inc. (AURA)

Hopkins Janet Jill โ€” Chief Medical Officer
Feb 17, 2026
Sale
Shares
20,401
Price
$5.06
Total Value
$103.23K
Shares Held After
232,284
% of Holdings
8.1%

Aura Biosciences, Inc. (AURA)

Elazzouzi Amy โ€” Senior Vice President, Finance
Feb 17, 2026
Sale
Shares
8,549
Price
$5.06
Total Value
$43.26K
Shares Held After
75,532
% of Holdings
10.2%

Aura Biosciences, Inc. (AURA)

Plavsic Mark โ€” Chief Technology Officer
Feb 17, 2026
Sale
Shares
15,890
Price
$5.05
Total Value
$80.24K
Shares Held After
181,397
% of Holdings
8.1%

Aura Biosciences, Inc. (AURA)

Kilroy Conor โ€” Chief Legal Officer and Secretary.
Feb 17, 2026
Sale
Shares
12,079
Price
$5.05
Total Value
$61.00K
Shares Held After
167,234
% of Holdings
6.7%
Feb 17, 2026
Sale
Shares
30,000
Price
$20.63
Total Value
$618.99K
Shares Held After
997,015
% of Holdings
2.9%

Tenaya Therapeutics, Inc. (TNYA)

Tingley Whittemore โ€” Chief Medical Officer
Feb 17, 2026
Sale
Shares
1,876
Price
$0.64
Total Value
$1.21K
Shares Held After
218,618
% of Holdings
0.9%

Tenaya Therapeutics, Inc. (TNYA)

Tingley Whittemore โ€” Chief Medical Officer
Feb 17, 2026
Sale
Shares
1,642
Price
$0.64
Total Value
$1.06K
Shares Held After
220,494
% of Holdings
0.7%

Tenaya Therapeutics, Inc. (TNYA)

Tingley Whittemore โ€” Chief Medical Officer
Feb 17, 2026
Sale
Shares
1,642
Price
$0.64
Total Value
$1.06K
Shares Held After
222,136
% of Holdings
0.7%

Tenaya Therapeutics, Inc. (TNYA)

Ali Faraz โ€” Director
Feb 17, 2026
Sale
Shares
5,032
Price
$0.64
Total Value
$3.24K
Shares Held After
443,404
% of Holdings
1.1%

Tenaya Therapeutics, Inc. (TNYA)

Ali Faraz โ€” Director
Feb 17, 2026
Sale
Shares
3,979
Price
$0.64
Total Value
$2.56K
Shares Held After
448,436
% of Holdings
0.9%

Tenaya Therapeutics, Inc. (TNYA)

Ali Faraz โ€” Director
Feb 17, 2026
Sale
Shares
5,851
Price
$0.64
Total Value
$3.76K
Shares Held After
452,415
% of Holdings
1.3%

Tenaya Therapeutics, Inc. (TNYA)

Higa Tomohiro โ€” SVP, Finance
Feb 17, 2026
Sale
Shares
2,022
Price
$0.64
Total Value
$1.30K
Shares Held After
119,752
% of Holdings
1.7%

Tenaya Therapeutics, Inc. (TNYA)

Higa Tomohiro โ€” SVP, Finance
Feb 17, 2026
Sale
Shares
836
Price
$0.64
Total Value
$537.88
Shares Held After
121,774
% of Holdings
0.7%

Tenaya Therapeutics, Inc. (TNYA)

Higa Tomohiro โ€” SVP, Finance
Feb 17, 2026
Sale
Shares
611
Price
$0.64
Total Value
$393.12
Shares Held After
122,610
% of Holdings
0.5%
Feb 17, 2026
Sale
Shares
3,667
Price
$28.85
Total Value
$105.78K
Shares Held After
2,197,944
% of Holdings
0.2%
Feb 17, 2026
Sale
Shares
96,333
Price
$29.70
Total Value
$2.86M
Shares Held After
2,201,611
% of Holdings
4.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Feb 17, 2026
Sale
Shares
2,041
Price
$331.96
Total Value
$677.53K
Shares Held After
21,264
% of Holdings
8.8%
Feb 17, 2026
Purchase
Shares
20,000
Price
$5.30
Total Value
$106.00K
Shares Held After
207,000
% of Holdings
9.7%
Feb 17, 2026
Sale
Shares
1,200
Price
$127.00
Total Value
$152.40K
Shares Held After
230,743
% of Holdings
0.5%

Mineralys Therapeutics, Inc. (MLYS)

Rodman David Malcom โ€” Chief Medical Officer
Feb 17, 2026
Sale
Shares
417
Price
$27.59
Total Value
$11.51K
Shares Held After
44,089
% of Holdings
0.9%

Remitly Global, Inc. (RELY)

Blignaut Ryno โ€” Director
Feb 17, 2026
Sale
Shares
4,500
Price
$12.89
Total Value
$58.01K
Shares Held After
32,576
% of Holdings
12.1%

MSCI Inc. (MSCI)

Fernandez Henry A โ€” Director
Feb 17, 2026
Purchase
Shares
200
Price
$520.00
Total Value
$104.00K
Shares Held After
1,493,847
% of Holdings
0.0%

MSCI Inc. (MSCI)

Fernandez Henry A โ€” Director
Feb 17, 2026
Purchase
Shares
360
Price
$519.45
Total Value
$187.00K
Shares Held After
1,493,647
% of Holdings
0.0%

MSCI Inc. (MSCI)

Fernandez Henry A โ€” Director
Feb 17, 2026
Purchase
Shares
240
Price
$517.32
Total Value
$124.16K
Shares Held After
1,493,287
% of Holdings
0.0%

Dolby Laboratories, Inc. (DLB)

Revankar Shriram โ€” SVP, Advanced Technology Group
Feb 17, 2026
Sale
Shares
3,000
Price
$66.14
Total Value
$198.42K
Shares Held After
83,218
% of Holdings
3.5%
Version: v26.3.33